other material
confidence high
sentiment neutral
materiality 0.45
Lakewood-Amedex holders approve raising authorized shares to 100M and reverse split up to 1:20
Lakewood-Amedex Biotherapeutics Inc.
- Stockholders approved increasing authorized common stock from 12,500,000 to 100,000,000 shares (927,022 for, 341,843 against, 711 abstain).
- Board authorized, at its discretion, to effect one or more reverse stock splits at a cumulative ratio not exceeding 1-for-20 (922,614 for, 333,546 against).
- 2020 Equity Incentive Plan amended to raise shares issuable thereunder to 400,000 (951,373 for, 317,012 against, 1,191 abstain).
- All four nominees elected as directors: Kelvin Cooper, Doug Manion, Leonard J. DeRoma and Joseph Tucker, each with roughly 939,000-976,000 votes for.
- CBIZ CPAs P.C. ratified as independent auditor (1,041,961 for, 33,322 against, 238,766 abstain); 2,369,688 shares were outstanding as of the July 30, 2026 record date.